Chemotherapy-induced intestinal injury promotes Galectin-9-driven modulation of T cell function

Suze A. Jansen(Utrecht University), Caroline A. Lindemans(Princess Máxima Center)

bioRxiv (Cold Spring Harbor Laboratory)

April 30, 2023

10.1101/2023.04.30.538862

Cited by 3

Related Papers

Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults

|Blood|2020|161

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

|Blood|2012|77

Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management

|European Journal of Paediatric Neurology|2024|28

Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior

|iScience|2024|3